About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBiotech
Team (11)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
189
By Phase
PHASE3: 2PHASE2: 2
By Status
RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06881992Lead Sponsor
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
PHASE3Recruiting
16 participants
Started: Apr 16, 2025 · Completed: Sep 30, 2027
NCT06208215Lead Sponsor
RZ358 Treatment for Congenital Hyperinsulinism
PHASE3Recruiting
56 participants
Started: Jan 11, 2024 · Completed: Sep 28, 2026
NCT05712720Lead Sponsor
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
PHASE2Completed
94 participants
Started: Feb 6, 2023 · Completed: Apr 11, 2024
NCT04538989Lead Sponsor
An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
PHASE2Completed
23 participants
Started: Feb 24, 2020 · Completed: Aug 19, 2022
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...